BIOTIME INC SC 13D 10-1-2013 (ASTERIAS BIOTHERAPEUTICS INC)

Company

Lineage Cell Therapeutics, Inc.

Filed

October 9, 2013

Accession Number

0001140361-13-038229

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →